IDRx tests treatment for digestive system cancer that affects 4,000 to 6,000 people a year in USRead More
You might also be interested in reading John Marshall Bancorp GAAP EPS of $0.36, revenue of $15.43M.
IDRx tests treatment for digestive system cancer that affects 4,000 to 6,000 people a year in USRead More
You might also be interested in reading John Marshall Bancorp GAAP EPS of $0.36, revenue of $15.43M.